Feasibility and acceptability of an antiretroviral treatment as prevention (TasP) intervention in rural South Africa: results from the ANRS 12249 TasP cluster-randomised trial

Communications Wednesday 16 July 2014

Oral communication presented at the 20^th International AIDS Conference in Melbourne in July 2014 (session WEAC01 Maximizing the Preventive Benefits of Treatment: Evolving Views).

Authors

Collins Iwuji¹, Joanna Orne-Gliemann², Frank Tanser¹, Rodolphe Thiébaut², Joseph Larmarange³, Nonhlanhla Okesola¹, Marie-Louise Newell⁴, François Dabis²

Africa Centre for Health and Population Studies, University of KwaZulu-Natal, Somkhele, South Africa
Bordeaux University, Institut de Santé Publique, Epidemiologie et Developpement, Bordeaux, France
Centre Population et Développement (CEPED UMR 196 Université Paris Descartes-Ined-IRD), Paris, France
University of Southampton, Faculty of Medicine, Faculty of Social and Human Sciences, Southampton, United Kingdom

Citation

Iwuji Collins, Orne-Gliemann Joanna, Tanser Frank, Thiébaut Rodolphe, Larmarange Joseph, Okesola Nonhlanhla, Newell Marie-Louise and Dabis François (2014) “Feasibility and acceptability of an antiretroviral treatment as prevention (TasP) intervention in rural South Africa: results from the ANRS 12249 TasP cluster-randomised trial” (communication orale n°WEAC0105LB), presented at the 20th International AIDS Conference, Melbourne. http://pag.aids2014.org/session.aspx?s=1118.